• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. EUFLEXXA; 1% SODIUM HYALURONATE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. EUFLEXXA; 1% SODIUM HYALURONATE Back to Search Results
Catalog Number 6301182010
Device Problem Off-Label Use (1494)
Patient Problem Death (1802)
Event Date 02/26/2019
Event Type  Death  
Event Description
Patient passed away [death].Bilateral primary osteoporosis of knee (off label use) [off label use of device].Drug use for unapproved indication [device use issue].Case (b)(4) is a serious spontaneous case received from a non-health professional via regulatory authority in united states.This report concerns a patient of unknown age and gender who had passed away during treatment with euflexxa (sodium hyaluronate) solution for injection 10 mg/ml, unknown dose and route of administration, for bilateral primary osteoporosis of knee (off label use of device [device use for unapproved indication]) from an unknown start date to an unknown stop date and the co-suspect drug synvisc one (hylan g-f 20) for an unknown indication on unknown dates.On (b)(6) 2019, the patient passed away.The reason for patient death was not reported.Action taken with euflexxa was not applicable.At the time of this report, the outcome of off label use of device and device use for unapproved indication were unknown.No concomitant medication was reported.At the time of reporting the case outcome was fatal.Overall listedness (core label) is unlisted.Reporter causality: not provided.Company causality: not related.Other case numbers: internal # - others = mw5088228.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EUFLEXXA
Type of Device
1% SODIUM HYALURONATE
Manufacturer (Section D)
BIO-TECHNOLOGY GENERAL (ISRAEL) LTD.
be'er tuvia industrial zone
pob 571
kiryat malachi, 83104
IS  83104
Manufacturer (Section G)
BIO-TECHNOLOGY GENERAL (ISRAEL) LTD.
be'er tuvia industrial zone
pob 571
kiryat malachi, 83104
IS   83104
Manufacturer Contact
100 interpace parkway
parsippany, NJ 07054
9737961600
MDR Report Key8934670
MDR Text Key155644324
Report Number3000164186-2019-00035
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Other
Type of Report Initial
Report Date 08/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date02/24/2020
Device Catalogue Number6301182010
Device Lot NumberP13138A
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/30/2019
Initial Date FDA Received08/27/2019
Is the Device Single Use? Yes
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Death;
-
-